Marios Myronakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marios Myronakis has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- John Damilakis
School of Medicine, University of Crete, Iraklion, Greece
3 shared publications John Stratakis
Department of Medical Physics, University Hospital of Iraklion, 71110 Iraklion, Crete, Greece
3 shared publicationsA Wang
Varian Medical Systems, Palo Alto, CA
1 shared publication- Alexandros G. Georgakilas
DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece
1 shared publication - Angeliki Gkikoudi
DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece
1 shared publication - Apostolos H. Karantanas
Department of Radiology, Medical School, University of Crete, Heraklion, Greece
1 shared publication
Latest Publications
- Open Access
From Cellular Radiosensitivity to Precision Radiotherapy: Integrating Functional Assays, Genomics, and Clinical Modeling
Background: Radiotherapy outcomes are determined by the balance between tumor control and normal tissue toxicity, both of which exhibit significant interpatient variability. While radiogenomic and molecular approaches have identified determinants of radiosensitivity, their predictive performance remains limited when used in isolation. Methods: This review provides a comprehensive synthesis of functional assays, genomic biomarkers, and integrative models used to assess radiosensitivity, including radiation-induced lymphocyte apoptosis (RILA), chromosomal radiosensitivity assays, micronucleus formation, γ-H2AX foci kinetics, comet assays, clonogenic survival, and patient-derived organoids, alongside genomic and molecular predictors of tumor response such as hypoxia signatures and gene expression-based models (e.g., RSI and GARD). Results: Functional assays provide direct phenotypic assessment of radiation response, capturing DNA repair capacity, chromosomal stability, apoptosis, and tissue regenerative potential, and have shown associations in several studies with normal tissue toxicity across clinical settings. Tumor radiosensitivity is influenced by intrinsic cellular factors and microenvironmental conditions, including hypoxia and genomic instability. Integrative approaches combining functional, genomic, and clinical data show increasing potential for improving predictive accuracy. Conclusions: Radiosensitivity should be considered a systems-level phenotype requiring multi-dimensional assessment. Conceptual frameworks that integrate tumor and normal tissue responses within a unified modeling approach, supported by measurable biological and clinical parameters, represent a promising direction for clinically actionable precision radiotherapy. The integration of functional assays with genomic and clinical modeling frameworks represents a promising strategy for advancing personalized radiotherapy and improving therapeutic outcomes.
Open AccessFrom Cellular Radiosensitivity to Precision Radiotherapy: Integrating Functional Assays, Genomics, and Clinical Modeling
Background: Radiotherapy outcomes are determined by the balance between tumor control and normal tissue toxicity, both of which exhibit significant interpatient variability. While radiogenomic and molecular approaches have identified determinants of radiosensitivity, their predictive performance remains limited when used in isolation. Methods: This review provides a comprehensive synthesis of functional assays, genomic biomarkers, and integrative models used to assess radiosensitivity, including radiation-induced lymphocyte apoptosis (RILA), chromosomal radiosensitivity assays, micronucleus formation, γ-H2AX foci kinetics, comet assays, clonogenic survival, and patient-derived organoids, alongside genomic and molecular predictors of tumor response such as hypoxia signatures and gene expression-based models (e.g., RSI and GARD). Results: Functional assays provide direct phenotypic assessment of radiation response, capturing DNA repair capacity, chromosomal stability, apoptosis, and tissue regenerative potential, and have shown associations in several studies with normal tissue toxicity across clinical settings. Tumor radiosensitivity is influenced by intrinsic cellular factors and microenvironmental conditions, including hypoxia and genomic instability. Integrative approaches combining functional, genomic, and clinical data show increasing potential for improving predictive accuracy. Conclusions: Radiosensitivity should be considered a systems-level phenotype requiring multi-dimensional assessment. Conceptual frameworks that integrate tumor and normal tissue responses within a unified modeling approach, supported by measurable biological and clinical parameters, represent a promising direction for clinically actionable precision radiotherapy. The integration of functional assays with genomic and clinical modeling frameworks represents a promising strategy for advancing personalized radiotherapy and improving therapeutic outcomes.
- 29 May 2024
- Published by Elsevier in Physica Medica
- Vol. 122, 103381
Is deep learning-enabled real-time personalized CT dosimetry feasible using only patient images as input?
- 29 May 2024
- Published by Elsevier in Physica Medica
- Vol. 122, 103381
Is deep learning-enabled real-time personalized CT dosimetry feasible using only patient images as input?
- 5 February 2024
- Published by Elsevier in Physica Medica
- Vol. 119, 103305
Organ dose prediction for patients undergoing radiotherapy CBCT chest examinations using artificial intelligence
- 5 February 2024
- Published by Elsevier in Physica Medica
- Vol. 119, 103305
Organ dose prediction for patients undergoing radiotherapy CBCT chest examinations using artificial intelligence
- 3 December 2023
- Published by Elsevier in Physica Medica
- Vol. 117, 103195
A fully automated machine learning-based methodology for personalized radiation dose assessment in thoracic and abdomen CT
- 3 December 2023
- Published by Elsevier in Physica Medica
- Vol. 117, 103195
A fully automated machine learning-based methodology for personalized radiation dose assessment in thoracic and abdomen CT
- 7 June 2016
- Published by Wiley in Medical Physics
- Vol. 43 (6Part40) , 3812-3813
WE-DE-BRA-04: A Cost-Effective Pixelated EPID Scintillator for Enhanced Contrast and DQE
- 7 June 2016
- Published by Wiley in Medical Physics
- Vol. 43 (6Part40) , 3812-3813
WE-DE-BRA-04: A Cost-Effective Pixelated EPID Scintillator for Enhanced Contrast and DQE